Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_assertion type Assertion NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_head.
- NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_assertion description "[Experimental results indicated that downregulation of HER2/neu by SM might be an effective strategy for enhancing drug susceptibility of breast cancer cells expressing high levels of HER2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_provenance.
- NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_assertion evidence source_evidence_literature NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_provenance.
- NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_assertion SIO_000772 17885815 NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_provenance.
- NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_assertion wasDerivedFrom befree-2016 NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_provenance.
- NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_assertion wasGeneratedBy ECO_0000203 NP631227.RAgRs1wgzBxTIdHZ-v8EvqG0MxONfSA3hit_vgIxpnh20130_provenance.